Product Information
CEFEPIME HCL 2 GRAM VIAL is a generic product labeled by WG Critical Care, LLC, priced at $5.3480 per EA under NDC 44567013110. Its NADAC has been published 22 times since Nov 20, 2024.
Strength
2 g/20mL
Manufacturer
WG Critical Care, LLCNDC
44567013110
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
3/19/2025
Active Ingredients
CEFEPIME HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA065441On Market Since
3/31/2021
Pharmacological Classes
Price Statistics
The NADAC for CEFEPIME HCL 2 GRAM VIAL has been published 22 times since Nov 20, 2024, and over the history we have for it it has declined 3.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.3480 per EA |
|---|---|
| All-time high | $5.5636 (Dec 11, 2024) |
| All-time low | $5.3480 (Mar 19, 2025) |
| Median price | $5.5424 |
| Average price | $5.4847 |
| Largest weekly change | -1.8% (Feb 19, 2025) |
| Weeks tracked | 22 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFEPIME HCL 2 GRAM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFEPIME HCL 2 GRAM VIAL, manufactured by WG Critical Care, LLC, is $5.3480 per EA (NDC 44567013110), effective Apr 16, 2025.
How has the price of CEFEPIME HCL 2 GRAM VIAL changed over time?
Over the history we have for it, the NADAC for CEFEPIME HCL 2 GRAM VIAL has declined 3.9%. It has been tracked across 22 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for CEFEPIME HCL 2 GRAM VIAL?
Since Nov 20, 2024, the NADAC for CEFEPIME HCL 2 GRAM VIAL has ranged from a low of $5.3480 (Mar 19, 2025) to a high of $5.5636 (Dec 11, 2024), with a median of $5.5424 per EA.
Are there cheaper alternatives to CEFEPIME HCL 2 GRAM VIAL?
4 NADAC-published products share the same active ingredient, strength, and dosage form as CEFEPIME HCL 2 GRAM VIAL, but none are currently priced below it.
Who manufactures CEFEPIME HCL 2 GRAM VIAL?
CEFEPIME HCL 2 GRAM VIAL (NDC 44567013110) is labeled by WG Critical Care, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification